Stockreport

Adagio Therapeutics GAAP EPS of -$1.81 [Seeking Alpha]

Invivyd, Inc.  (IVVD) 
PDF Based on current operating plans and excluding anticipated cash collections from PEMGARDA sales, Invivyd expects its existing total cash and cash equivalents will enabl [Read more]